Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/25 21:53 | 4/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Bellon Christine | MA | O | GC | 6 | S.d | -643 | 28.46 | 0 | -23 | 117 | D | |||||||||||||||
4/3/25 21:52 | 4/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Evans John M. | MA | DO | CEO | 7 | S.d | -8,444 | 26.49 | 0 | -319 | 1,179 | D | |||||||||||||||
4/3/25 21:51 | 4/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Ciaramella Giuseppe | MA | O | P | 4 | S.d | -2,972 | 26.03 | 0 | -114 | 190 | D | |||||||||||||||
4/3/25 21:50 | 4/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Cavanagh Bethany J | MA | O | SVP,Fina | 4 | S | -310 | 28.92 | 0 | -11 | 45 | D | |||||||||||||||
4/3/25 21:50 | 4/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Simon Amy | MA | O | Chief Me | 3 | S.m | -1,312 | 23.63 | 0 | -56 | 70 | D | |||||||||||||||
4/3/24 19:39 | 4/1/24 | BEAM | Health | BioPrd | Biological Products, (No Diag | Burrell Terry-Ann | MA | O | CFO | 1 | S | -175 | 32.12 | 0 | -5 | 70 | D | |||||||||||||||
2/15/24 14:34 | 2/13/24 | BEAM | Health | BioPrd | Biological Products, (No Diag | Fmr LLC | MA | H | See Rema | 1 | S.m | -27,545 | 30.55 | 0 | -902 | 4,007 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |